Indeed, we noted that treatment of breast cancer cells with tryptase affected the chromatin accessibility in several regions, including reduced chromatin accessibility in regions containing genes whose transcription were suppressed by tryptase (e.g., CCN1, CCN2). Here, CCN1 is linked to breast carcinoma.